CASH FLOW STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2007

     CONSOLIDATED    THE COMPANY     
R million Notes  2007  2006  2007  2006 
           
Cash flows – operating activities                
Consolidated profit before taxation     1 527  5 103  3 356  4 188 
Adjustments  23.1  309  (3 588) (3 358) (4 191)
Consolidatedprofit/(loss) before working capital                
   changes     1 836  1 515  (2) (3)
Working capital changes  23.2  (170) (41) (2)
Cash generated/(utilised) from operations     1 666  1 474  –  (5)
Cash flow generated from returns on investments     3 070  4 229  3 358  4 191 
   Interest received     334  341  –  – 
   Dividends received  23.3  2 736  3 888  3 358  4 191 
Finance cost     (30) (29) –  – 
Taxation paid  23.4  (676) (369) –  – 
Cash available from operating activities     4 030  5 305  3 358  4 186 
Dividends paid  23.5  (3 813) (4 676) (3 782) (4 860)
Cash inflow/(outflow) from operating activities     217  629  (424) (674)
                
Cash flows – investing activities                
Net investments to maintain operations     (109) (54) –  – 
   Replacement of property, plant and equipment     (124) (83) –  – 
   Proceeds on disposal of property, plant and equipment     15  29  –  – 
Investments to expand operations     (673) (1 362) –  – 
   Additions to – property, plant and equipment and other assets     (410) (607) –  – 
                          – investments and loans     (249) (609) –  – 
   Business acquired     (14) (146) –  – 
Proceeds from disposal of investments and loans     260  6 585  –  – 
Medi-Clinic’s cash transferred to associated company     –  (879) –  – 
Purchase of treasury shares     (1 203) (926) –  – 
Net cash generated/(utilised) before financing activities     (1 508) 3 993  (424) (674)
                
Cash flows – financing activities     70  99  424  674 
(Increase)/decrease in loans     40  93  424  5 209 
Issue of new shares by subsidiary companies     12  10  –  – 
Capital contributed by minorities of subsidiary company     18  –  – 
Shares cancelled     –  (11) –  (4 535)
Net increase/(decrease) in cash and cash equivalents     (1 438) 4 092  –  – 
Cash and cash equivalents at the beginning of the year     6 339  2 247  –  – 
Cash and cash equivalents at the end of the year     4 901  6 339  –  – 
           
Cash and cash equivalents – per balance sheet     5 004  6 357       
Bank overdraft     (103) (18)